LANTHEUS ANNOUNCES FDA APPROVAL OF PYLARIFY TRUVU™ (PIFLUFOLASTAT F 18) INJECTION
LANTHEUS HOLDINGS INC - PYLARIFY TRUVU EXPECTED TO LAUNCH IN Q4 2026 WITH PHASED ROLLOUT
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.